Something clarified for me in the Q&A was that the P2 trial isn't going to "double" as a registration study; they are hoping to run P2 and RS "in parallel.
That implies they will have separate cohorts of patients.
Ann: PTX-100 Spotlight Presentation, page-6
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.85M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.7¢ | 4.6¢ | $9.868K | 212.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 213388 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 276024 | 7 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.7¢ |
Change
0.000 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 4.7¢ | 4.5¢ | 243758 | ||
| Last updated 15.01pm 05/06/2024 ? | |||||
| PTX (ASX) Chart |